<DOC>
	<DOCNO>NCT00528151</DOCNO>
	<brief_summary>Background Leber 's Hereditary Optic Neuropathy ( LHON ) maternally inherit ocular disorder associate mutation mtDNA . The common manifestation visual loss cause respiratory chain enzyme complex dysfunction result increase oxidative stress enzyme production . Purpose To determine whether curcumin antioxidant agent beneficial patient 11778 LHON mutation . Material Method Seventy patient 11778 LHON mutation randomly treat oral curcumin ( 500 mg/day ) placebo 1 year . The visual acuity , computerized visual field , electrophysiologic parameter oxidative stress enzyme plasma compare treatment 3 , 6 , 12 month interval .</brief_summary>
	<brief_title>A Randomized , Double-blind , Placebo-controlled Trial Curcumin Leber 's Hereditary Optic Neuropathy ( LHON )</brief_title>
	<detailed_description>Leber 's hereditary optic neuropathy ( LHON ) maternally inherited disease characterize simultaneous common sequential bilateral loss central vision , typically occur teenager year early adulthood . The disease may progressive patient eventually become blind . In contrast blindness patient cause congenital disease , patient develop blindness cause LHON trouble life previously good vision . Although LHON associate mitochondrial DNA mutation variable nucleotide position certain mechanism optic nerve injury find . It postulate defect complex respiratory chain enzyme cause mitochondrial DNA dysfunction , result increase free radical substance interfere optic nerve function LHON . Some antioxidant substance use decrease progression visual impairment . However , therapeutic trial LHON . Curcumin , component tumeric , come root Curcumin longa antioxidant , anti-inflammatory anti-carcinogenic activity . There evidence suggest curcumin contributes vitro removal free radical gradient thalassemic serum clinical improvement thalassemic patient . We propose randomize controlled trial study curcumin , antioxidant substance , LHON . This study provide insight therapeutic efficacy curcumin , kind Thai herb , LHON also development future therapeutic strategy prevent blindness .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Optic Nerve Diseases</mesh_term>
	<mesh_term>Optic Atrophy , Hereditary , Leber</mesh_term>
	<mesh_term>Optic Atrophy</mesh_term>
	<mesh_term>Optic Atrophies , Hereditary</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>LHON patient 11778 point mutation LHON patient point mutation</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2004</verification_date>
	<keyword>Curcumin , LHON , antioxidant , visual outcome</keyword>
</DOC>